Radionuclide therapy via SSTR: future aspects from experimental animal studies.

Radionuclide therapy via SSTR: future aspects from experimental animal studies.

Item
http://www.wikidata.org/entity/Q38008839
Distinct microRNA expression profiles in mouse renal cortical tissue after 177Lu-octreotate administrationEvaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with (177)Lu-octreotatePotential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in MiceEvaluation of two intraoperative gamma detectors for assessment of 177Lu activity concentration in vivo.Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude miceThe amount of injected 177Lu-octreotate strongly influences biodistribution and dosimetry in C57BL/6N mice.The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
P2860

Radionuclide therapy via SSTR: future aspects from experimental animal studies.

Item
http://www.wikidata.org/entity/Q38008839
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radionuclide therapy via SSTR: future aspects from experimental animal studies.
@en
type
label
Radionuclide therapy via SSTR: future aspects from experimental animal studies.
@en
prefLabel
Radionuclide therapy via SSTR: future aspects from experimental animal studies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Radionuclide therapy via SSTR: future aspects from experimental animal studies.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698